Your browser doesn't support javascript.
loading
Vaccinia Virus Vectors Targeting Peptides for MHC Class II Presentation to CD4+ T Cells.
Hobbs, Samuel J; Harbour, Jake C; Yates, Phillip A; Ortiz, Diana; Landfear, Scott M; Nolz, Jeffrey C.
Afiliação
  • Hobbs SJ; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239.
  • Harbour JC; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239.
  • Yates PA; Department of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, OR 97239.
  • Ortiz D; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239.
  • Landfear SM; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239.
  • Nolz JC; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239; nolz@ohsu.edu.
Immunohorizons ; 4(1): 1-13, 2020 01 02.
Article em En | MEDLINE | ID: mdl-31896555

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vaccinia virus / Linfócitos T CD4-Positivos / Antígenos de Histocompatibilidade Classe II / Linfócitos T CD8-Positivos Limite: Animals Idioma: En Revista: Immunohorizons Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vaccinia virus / Linfócitos T CD4-Positivos / Antígenos de Histocompatibilidade Classe II / Linfócitos T CD8-Positivos Limite: Animals Idioma: En Revista: Immunohorizons Ano de publicação: 2020 Tipo de documento: Article